News
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
22 Apr 24
Biotech, Equities, News, Health Care, Legal, Movers, Trading Ideas, General
'The U.S Supreme Court Has Reportedly Declined To Hear Vanda Pharmaceuticals' Case Regarding The Invalidation Of Certain Patents For Its Sleep-Wake Disorder Drug Hetlioz, That Were Previously Declared Invalid In A Dispute With Generic Drugmakers Teva And Apotex' - Yahoo Finance
22 Apr 24
Biotech, News, Legal, General
Alvotech, Teva Announce US FDA Approval Of SELARSDI, Biosimilar To Stelara
16 Apr 24
News, FDA
Teva's New Real-World Evidence Presented At The 2024 AAN Annual Meeting Confirms Effectiveness And Patient Satisfaction For HD Chorea With The 4-week Titration Kit For AUSTEDO Tablets
16 Apr 24
Biotech, News, General
Reported Saturday, Teva Pharmaceuticals Presented New Pharmacokinetic Modeling Data By Simulates Clinical Profiles Of Schizophrenia Patients Switching To UZEDY® Extended-Release Injectable Suspension At SIRS 2024
8 Apr 24
News
UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals Alleging Infringement Of US Patent Numbers 9,040,074 And 9,950,069
3 Apr 24
News, Legal
'Supreme Court Unlikely To Limit Access To Abortion Pill' - Washington Post
26 Mar 24
Biotech, News, Legal, General
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
25 Mar 24
Long Ideas, News, Small Cap, Top Stories, Markets, Media, Trading Ideas
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month
21 Mar 24
Biotech, Large Cap, News, Health Care, General
8 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
8 Mar 24
Analyst Ratings
JP Morgan Upgrades Teva Pharmaceutical Indus to Neutral, Announces $14 Price Target
8 Mar 24
News, Upgrades, Price Target, Analyst Ratings
'France becomes first country to explicitly enshrine abortion rights in constitution' -Washington Post Report
4 Mar 24
News, Politics, General
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
26 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
10 Health Care Stocks With Whale Alerts In Today's Session
26 Feb 24
Options
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
26 Feb 24
Large Cap, News, Health Care, FDA, Movers, General
Teva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: Report
20 Feb 24
Biotech, Large Cap, M&A, News, Health Care, General
Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise
12 Feb 24
Analyst Color, Long Ideas, News, Upgrades, Price Target, Top Stories, Analyst Ratings, Movers, Trading Ideas
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
12 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday
12 Feb 24
News, Price Target, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
Beyond The Numbers: 8 Analysts Discuss Teva Pharmaceutical Indus Stock
12 Feb 24
Analyst Ratings
Press releases
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16 Apr 24
Press Releases
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
11 Apr 24
Press Releases
Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
9 Apr 24
Press Releases
New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
6 Apr 24
Press Releases
Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
4 Apr 24
Press Releases
Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China
26 Feb 24
Press Releases
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
23 Feb 24
Press Releases
Teva Reports Growth in Fourth Quarter and Full Year 2023
31 Jan 24
Press Releases
Teva Announces Intention to Divest API Business as Part of Pivot to Growth Strategy
31 Jan 24
Press Releases